Literature DB >> 6789334

Von Willebrand syndrome induced by a Bothrops venom factor: bioassay for venom coagglutinin.

K M Brinkhous, D S Barnes, J Y Potter, M S Read.   

Abstract

Hereditary deficiency of the macromolecular Factor VIII complex results in classic von Willebrand disease in man and animals, a bleeder state characterized by loss of the multiple biologic activities associated with the Factor VIII complex, including the platelet-aggregating von Willebrand factor. The bleeding time is also long. Venom coagglutinin, a Bothrops factor that causes platelet aggregation in vitro, depletes the plasma of its von Willebrand factor. The rate of platelet aggregation is a function of the amount of the coagglutinin present. Based on this observation, a sensitive and quantitative assay for the venom coagglutinin was developed. We administered the purified Bothrops factor to normal pigs and dogs and induced a von Willebrand syndrome similar to the inherited disease. The plasma von Willebrand factor was severely depleted; the antihemophilic factor and the Factor VIII-related antigen were not depleted as much. The bleeding time was normal. During the induction phase of the syndrome, transient thrombocytopenia with a long bleeding time occurred. The pig was less sensitive than the dog to the effect of coagglutinin. The severity of the syndrome is determined by the amount of venom coagglutinin administered. It is suggested that the syndrome could be induced in any mammalian species because the plasma of all mammals tested in vitro is sensitive to the venom factor. This model provides another avenue for the study of the heterogeneity of the Factor VIII complex and the pathophysiology of its components.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6789334      PMCID: PMC319535          DOI: 10.1073/pnas.78.5.3230

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Plasmatic clotting and/or blood cellular clumping in clinical conditions, experimental animals, and in perfused organs.

Authors:  K M Brinkhous; H R Culp
Journal:  Thromb Res       Date:  1976-05       Impact factor: 3.944

2.  Preservation of platelet receptors for platelet aggregating factor/von Willebrand factor by air drying, freezing, or lyophilization: new stable platelet preparations for von Willebrand factor assays.

Authors:  K M Brinkhous; M S Read
Journal:  Thromb Res       Date:  1978-10       Impact factor: 3.944

3.  Plasma levels of platelet aggregating factor/vom Willebrand factor in various species.

Authors:  K M Brinkhous; B D Thomas; S A Ibrahim; M S Read
Journal:  Thromb Res       Date:  1977-09       Impact factor: 3.944

4.  Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor.

Authors:  M S Read; R W Shermer; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

5.  Macromolecular factor VIII complex: functional and structural heterogeneity observed in von Willebrand swine with transfusion.

Authors:  T R Griggs; J S Potter; S B McClanahan; W P Webster; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

6.  Genetics of classic von Willebrand's disease. I. Phenotypic variation within families.

Authors:  C H Miller; J B Graham; L R Goldin; R C Elston
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

7.  Antihemophilic factor concentrate therapy in von Willebrand disease. Dissociation of bleeding-time factor and ristocetin-cofactor activities.

Authors:  P M Blatt; K M Brinkhous; H R Culp; J S Krauss; H R Roberts
Journal:  JAMA       Date:  1976-12-13       Impact factor: 56.272

8.  Platelet-aggregating factor and the aggregation of fixed washed platelets.

Authors:  H A Cooper; K W Wilkins; P R Johnson; R H Wagner
Journal:  J Lab Clin Med       Date:  1977-09

9.  Selective absence of large forms of factor VIII/von Willebrand factor in acquired von Willebrand's syndrome. Response to transfusion.

Authors:  D Meyer; D Frommel; M J Larrieu; T S Zimmerman
Journal:  Blood       Date:  1979-09       Impact factor: 22.113

10.  Antibody nature of circulating inhibitor of plasma von Willebrand factor.

Authors:  R D Stratton; R H Wagner; W P Webster; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

View more
  2 in total

1.  Botrocetin (venom coagglutinin): reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex.

Authors:  K M Brinkhous; M S Read; W A Fricke; R H Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

2.  Platelet clearance via shear-induced unfolding of a membrane mechanoreceptor.

Authors:  Wei Deng; Yan Xu; Wenchun Chen; David S Paul; Anum K Syed; Matthew A Dragovich; Xin Liang; Philip Zakas; Michael C Berndt; Jorge Di Paola; Jerry Ware; Francois Lanza; Christopher B Doering; Wolfgang Bergmeier; X Frank Zhang; Renhao Li
Journal:  Nat Commun       Date:  2016-09-27       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.